Skip to main content
. 2024 Oct 2;10(6):e70004. doi: 10.1002/2056-4538.70004

Table 6.

Clinical analysis based on predominant growth pattern and EGFR mutation

Predominant growth pattern EGFR wild‐type (n = 69) EGFR mutation (n = 128) p value
Lepidic N 68 115 0.0479
Y 1 13
Solid N 53 118 0.0047
Y 16 10
Acinar N 28 36 0.1049
Y 41 92
Papillary N 64 120 1
Y 5 8
Micropapillary N 66 125 0.7291
Y 3 3

Results of distribution difference analysis by chi‐square test of predominant histopathological growth patterns (lepidic, solid, acinar, papillary, and micropapillary) according to the presence or absence of EGFR mutations.

HHS Vulnerability Disclosure